New therapeutic strategies based on biasing IL-2 mutants for cancers and autoimmune diseases
- 19 June 2022
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 110, 108935
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell DifferentiationImmunity, 2012
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’Nature, 2012
- Mast Cell Interleukin-2 Production Contributes to Suppression of Chronic Allergic DermatitisImmunity, 2011
- Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineagesNature Immunology, 2011
- Identification, frequency, activation and function of CD4+ CD25highFoxP3+ regulatory T cells in children with juvenile idiopathic arthritisRheumatology International, 2011
- Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T CellsImmunity, 2010
- Transcriptional Repressor Blimp-1 Promotes CD8+ T Cell Terminal Differentiation and Represses the Acquisition of Central Memory T Cell PropertiesImmunity, 2009
- Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLsJournal of Experimental Medicine, 2009
- Linked T Cell Receptor and Cytokine Signaling Govern the Development of the Regulatory T Cell RepertoireImmunity, 2008
- Interleukin-2 receptor signaling in regulatory T cell development and homeostasisImmunology Letters, 2007